ClinVar Miner

Submissions for variant NM_152594.3(SPRED1):c.1283G>A (p.Arg428His)

gnomAD frequency: 0.00006  dbSNP: rs369492789
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000690176 SCV000817855 uncertain significance Legius syndrome 2023-10-20 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 428 of the SPRED1 protein (p.Arg428His). This variant is present in population databases (rs369492789, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with SPRED1-related conditions. ClinVar contains an entry for this variant (Variation ID: 569525). Advanced modeling performed at Invitae incorporating data from internal and/or published experimental studies (Invitae) indicates that this missense variant is not expected to disrupt SPRED1 function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
GeneDx RCV001756174 SCV001986456 uncertain significance not provided 2021-03-18 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Ambry Genetics RCV002386187 SCV002691259 uncertain significance Cardiovascular phenotype 2021-10-01 criteria provided, single submitter clinical testing The p.R428H variant (also known as c.1283G>A), located in coding exon 7 of the SPRED1 gene, results from a G to A substitution at nucleotide position 1283. The arginine at codon 428 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.